PhotoMedex Inc  

(Public, NASDAQ:PHMD)   Watch this stock  
Find more results for PHMD
+0.88 (23.53%)
Real-time:   1:46PM EST
NASDAQ real-time data - Disclaimer
Currency in USD
Range 4.00 - 5.60
52 week 0.90 - 5.60
Open 4.00
Vol / Avg. 1.09M/99,525.00
Mkt cap 20.15M
P/E     -
Div/yield     -
EPS -9.82
Shares 4.36M
Beta 0.64
Inst. own 18%

Key stats and ratios

Q3 (Sep '16) 2015
Net profit margin -102.19% -52.49%
Operating margin -99.57% -53.00%
EBITD margin - -22.10%
Return on average assets -126.44% -35.86%
Return on average equity -1426.15% -144.95%
Employees 76 -
CDP Score - -


100 Lakeside Dr Ste 100
HORSHAM, PA 19044-2352
United States - Map
+1-215-6193600 (Phone)
+1-215-6193208 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


PhotoMedex, Inc. is a global health products and services company providing integrated disease management and solutions to dermatologists, professional aestheticians and consumers. The Company provides products and services that address skin diseases and conditions, including acne and photo damage. It operates through three business segments: Consumer segment, Physician Recurring segment and Professional segment. It provides skin health solutions to spa markets, as well as traditional retail, online and infomercial outlets for home-use products. Through its subsidiary, Radiancy, Inc., it offers home-use devices under no!no! brand for indications, including hair removal, acne treatment, skin rejuvenation and lower back pain. Its professional product line includes offerings for acne clearance, skin tightening, psoriasis care and hair removal. It is also engaged in the development, manufacture and sale of surgical products, including free-beam and contact laser systems for surgery.

Officers and directors

Lewis C. Pell Non-Executive Independent Chairman of the Board of Directors
Age: 71
Bio & Compensation  - Reuters
Dennis M. McGrath President, Chief Financial Officer, Director
Age: 59
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Dolev Rafaeli Chief Executive Officer, Director
Age: 51
Bio & Compensation  - Reuters
Yoav Ben-Dror Non-Executive Independent Vice Chairman of the Board
Age: 62
Bio & Compensation  - Reuters
Trevor S. Harris Ph.D. Director
Age: 60
Bio & Compensation  - Reuters
Stephen P Connelly Independent Director
Age: 63
Bio & Compensation  - Reuters
James W Sight Independent Director
Age: 59
Bio & Compensation  - Reuters